Geron Corp (GERN)

[postman]

It's all about the data. If the trials at Mayo and at Geron produce positive results, FDA approval and a much higher stock price will follow, not necessarily in that order. As investors, our next best chance to learn more about that data may be the AACR 2014 conference in about six weeks. With that in mind, this is from the AACR website...

"PUBLICATION OF ABSTRACTS

To assist attendees in planning their schedule for the meeting, accepted abstract titles will be made available online beginning February 19. Abstract bodies will not be made available online until March 5, one month prior to the meeting. (Late-Breaking Abstracts will be made available on April 4, the day before the start of the meeting.) Abstracts that have been selected for inclusion in the AACR press program will be made publicly available at the date and time of their presentation, either at the meeting or an official AACR press conference."